Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{164526,
        author = {Dr USMANI HUMAIRA SHADAB},
        title = {PATIENT SAFETY THROUGH ADVERSE DRUG REACTIONS MONITORING AND THERE MANAGEMENTS},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {10},
        number = {12},
        pages = {2923-2924},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=164526},
        abstract = {Adverse drug reactions (ADRs) pose a significant threat to patient safety and healthcare quality worldwide. This paper examines the complexities of ADR monitoring and management within clinical practice settings, focusing on strategies to identify, report, and mitigate ADRs effectively. Key components of pharmacovigilance systems, including signal detection, causality assessment, and risk communication, are explored. Additionally, innovative approaches such as electronic health record integration, machine learning algorithms, and patient-centered initiatives are discussed. Despite advancements, challenges persist, including underreporting, data fragmentation, and resource constraints. By addressing these challenges and leveraging technological innovations, healthcare providers can enhance ADR detection, improve patient outcomes, and promote medication safety.},
        keywords = {Adverse drug reactions, pharmacovigilance, medication safety, signal detection, causality assessment, risk communication, electronic health records, machine learning, patient-centered care.},
        month = {},
        }